Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

The New England Journal of Medicine
S E SallanN E Zinberg

Abstract

Delta-9-tetrahydrocannabinol (THC) is an effective antiemetic as compared with placebos in patients receiving chemotherapy for cancer. In this study we compared THC with prochlorperazine (compazine) in a randomized, double-blind, crossover trial with patients who had failed to benefit from standard antiemetic therapy. Regardless of the emetic activity of the chemotherapeutic agents, there were more complete responses to THC courses (in 36 of 79 courses) than to prochlorperazine (in 16 of 78 courses). Of 25 patients who were treated with both drugs and who expressed a preference, 20 preferred THC (P = 0.005). Among patients under 20 years of age there was a higher proportion of complete responses to THC courses (15 of 20) than among older patients (21 of 59 courses; P = 0.004). Increased food intake occurred more frequently with THC (P = 0.008) and was associated with the presence of a "high." Of 36 THC courses resulting in complete antiemetic responses, 32 were associated with a high. We conclude that THC is an effective antiemetic in many patients who receive chemotherapy for cancer and for whom other antiemetics are ineffective. (N Engl J Med 302:135--138, 1980).

References

Apr 6, 1978·The New England Journal of Medicine·M ten Ham, Y de Jong
Oct 16, 1975·The New England Journal of Medicine·S E SallanE Frei
Dec 13, 1968·Science·A T WeilJ M Nelsen
Nov 1, 1971·Anesthesia and Analgesia·K G ShieldsB N Hathaway
Jan 1, 1971·Clinical Pharmacology and Therapeutics·L E Hollister

❮ Previous
Next ❯

Citations

Jan 3, 2001·Medicinal Research Reviews·J M ArgilésF J López-Soriano
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·S G AllanR C Leonard
Sep 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A L Billett, S E Sallan
Sep 1, 1989·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·R CrambG Hirano
Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·T F PlasseR G Wadleigh
Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·R D MattesM A Elsohly
Oct 1, 1989·European Journal of Cancer & Clinical Oncology·I N OlverB L Hillcoat
Jul 8, 2000·European Journal of Pharmacology·A H LichtmanB R Martin
Jan 10, 1981·Lancet·J M Harper
Jan 20, 1999·Alimentary Pharmacology & Therapeutics·R W McCallumM W Plankey
Jun 12, 1980·The New England Journal of Medicine·C M Huguley
Feb 18, 1982·The New England Journal of Medicine·C R Blagg
Jul 22, 1982·The New England Journal of Medicine
Dec 9, 1982·The New England Journal of Medicine·G R Morrow, C Morrell
Dec 9, 1993·The New England Journal of Medicine·S M Grunberg, P J Hesketh
Jan 1, 1994·Drug and Alcohol Review·G B ChesherJ P Morgan
Feb 24, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T D BrisboisW V Wismer
Apr 24, 1982·British Medical Journal·D N Bateman, M D Rawlins
Jan 29, 1983·British Medical Journal·J R Trounce
Sep 28, 1985·British Medical Journal·D CunninghamC S McArdle
May 23, 1998·Annual Review of Pharmacology and Toxicology·C C Felder, M Glass
Mar 22, 2003·Clinical Pharmacokinetics·Franjo Grotenhermen
Nov 6, 2007·Expert Opinion on Emerging Drugs·Josep M ArgilésSílvia Busquets
Dec 22, 2007·Expert Opinion on Investigational Drugs·Mellar P Davis
Jan 1, 1992·Cancer Investigation·K S SridharV Cairns
Jan 1, 1984·Cancer Investigation·J J Fiore, R J Gralla
Oct 31, 2015·Annual Review of Medicine·Samuel T WilkinsonDeepak Cyril D'Souza
Apr 1, 1983·Drug and Alcohol Dependence·L E Hollister
Oct 1, 1985·General Hospital Psychiatry·H JaegerF Brescia
Jun 1, 1983·British Journal of Clinical Pharmacology·D N Bateman
Aug 1, 1981·Journal of Clinical Pharmacology·J T Ungerleider, T Andrysiak
Aug 1, 1981·Journal of Clinical Pharmacology·M StaquetY Kenis
Aug 1, 1981·Journal of Clinical Pharmacology·J S PentaJ S Macdonald
Aug 1, 1981·Journal of Clinical Pharmacology·L E McCarthy, H L Borison
Jun 1, 1983·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·L ZeltzerJ Dash
Feb 1, 1985·European Journal of Cancer & Clinical Oncology·R J Gralla
Apr 30, 1998·The Annals of Pharmacotherapy·D L BalogM I Amodio-Groton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.